89bio, Inc. (ETNB)
NASDAQ: ETNB · IEX Real-Time Price · USD
9.35
+0.04 (0.43%)
Apr 23, 2024, 1:57 PM EDT - Market open
89bio Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for 89bio stock have an average target of 29, with a low estimate of 14 and a high estimate of 37. The average target predicts an increase of 210.16% from the current stock price of 9.35.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for 89bio stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 4 |
| Buy | 4 | 4 | 3 | 3 | 2 | 2 |
| Hold | 0 | 0 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +220.86% | Apr 22, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $29 | Buy | Reiterates | $29 | +210.16% | Apr 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +231.55% | Mar 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +231.55% | Mar 13, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $29 → $37 | Buy | Maintains | $29 → $37 | +295.72% | Mar 7, 2024 |
Financial Forecast
Revenue This Year
1.09M
Revenue Next Year
2.55M
from 1.09M
Increased by 133.30%
EPS This Year
-2.11
from -2.00
EPS Next Year
-2.67
from -2.11
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.9M | 18.4M | 50.2M | 419.3M | 1.1B |
| Avg | 1.1M | 2.6M | 30.7M | 184.3M | 533.4M |
| Low | n/a | n/a | 7.4M | 61.6M | 192.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 1,581.2% | 1,868.7% | 1,267.2% | 481.2% |
| Avg | - | 133.3% | 1,102.6% | 500.9% | 189.5% |
| Low | - | - | 190.8% | 101.0% | 4.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.63 | -1.77 | -0.72 | -1.52 | 0.55 |
| Avg | -2.11 | -2.67 | -2.52 | -2.25 | -1.01 |
| Low | -2.76 | -3.33 | -3.47 | -2.76 | -2.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.